The Centers for Medicare & Medicaid Services released part two of the Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Standards final rule.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
The Centers for Medicare & Medicaid Services released the Fiscal Year (FY) 2022 Medicare Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. The proposed rule would update the Medicare fee-for-service payment rates and policies for inpatient hospitals and long-term care hospitals for FY 2022.
From April 12-16, U.S. members of the Association for Clinical Oncology (ASCO) participated in the 2021 ASCO Advocacy Summit, where 148 advocates from 44 states and the District of Columbia held 222 virtual meetings – the most ever held during an Advocacy Summit – with Members of Congress and staff to urge action on important policies to improve access to high-quality, equitable care for people with cancer.
UPDATE: On Tuesday, April 13, 2021, the House passed the Senate bill to extend the moratorium on the 2% Medicare sequestration cuts through the end of the calendar year. President Biden signed the bill into law on Wednesday, April 14, 2021. CMS has resumed processing claims.
Both chambers of the United States Congress recently passed separate bills to extend the temporary moratorium on the 2% sequestration cut to Medicare reimbursement. The moratorium is currently set to expire on March 31, 2021, and both bills would extend the moratorium until December 31, 2021. However, since the House and Senate legislation differ, further action is needed before the extension becomes law.
The Association for Clinical Oncology (ASCO) is holding its 2021 ASCO Advocacy Summit Week of Action from April 12-16. During the Week of Action, ASCO members can visit ASCO’s easy-to-use ACT Network to quickly and efficiently contact their lawmakers to urge them to take action on cancer policy priorities.
The Centers for Medicare & Medicaid Services (CMS) announced it will hold physicians harmless from Merit-based Incentive Payment System (MIPS) penalties due to the significant disruptions the COVID-19 public health emergency placed on physician practices’ performance in 2020.
The American Society of Clinical Oncology’s (ASCO) Road to Recovery Report: Learning from the COVID-19 Experience to Improve Clinical Research and Cancer Care, among other recommendations, calls for the U.S. Department of Health and Human Services (HHS) to establish a special enrollment period on the federal health insurance exchange, abandon plans that limit access to healthcare, and enact policies that enhance access to care for patients with cancer. ASCO applauds the Biden administration for its recent actions supporting policies that aim to promote and protect access to high-quality, equitable cancer care, as outlined in the “Road to Recovery” report.
The Centers for Medicare & Medicaid Services (CMS) announced a revised Medicare Physician Fee Schedule (PFS) Conversion Factor (CF) of $34.8931 for 2021. This represents a 3.3% reduction from the 2020 CF of $36.0869. CMS updated the CF as a result of a provision in the $1.4 trillion Consolidated Appropriations Act of 2021 (H.R 133), which was signed into law on December 27, 2020.